Media
Latest News
Washington, D.C. – Representative Gus Bilirakis (R-FL) introduced H.R. 192, the Stop Handouts to Unauthorized Taxpayers (SHUT) Act, which would require any individual who receives the refundable portion of the child tax credit to demonstrate their legal employment in the United States by providing a Social Security Number or proof of lawful residence on their tax return.
Washington, D.C. – Representative Gus Bilirakis, member of the House Energy and Commerce Committee, today joined an overwhelmingly bipartisan effort to pass H.R. 3 in the House of Representatives, a bill to approve the Keystone XL pipeline.
Washington, D.C. – Representative Gus Bilirakis (R-FL), today voted with a bipartisan group of his colleagues to pass H.R. 30, the Save American Workers Act. This legislation would restore the definition of being a full-time employee to one who works a 40-hour work week, as opposed to a 30-hour work week that was implemented under the Affordable Care Act.
Washington, D.C. – Congressman Gus M. Bilirakis (R-FL), Vice Chairman of the Veterans Affairs Committee today voted to pass H.R. 22, the Hire More Heroes Act, of which he was an original cosponsor.
Washington, D.C. – Congressman Gus Bilirakis (R-FL) released the following statement following H.R. 83 being signed into law, which included H.R. 4450, the Travel Promotion, Enhancement, and Modernization Act, Bilirakis’ legislation to reauthorize Brand USA:
Roy Gifford thought he would be this way for the rest of his life: weighed down by schizoaffective disorder, working his way down a long list of medications, all hope extinguished.
Washington, D.C. – Representative Gus Bilirakis (R-FL), member of the Energy and Commerce Health Subcommittee, is honored to host a conversation about Mental Health and Substance Abuse issues, featuring Representative Tim Murphy, clinical psychologist and author of the bipartisan H.R.
Washington, D.C. – Representative Gus Bilirakis (R-FL), today announced a Holiday Open House in his Tarpon Springs District Office. To RSVP please call (727) 940-5860.
Florida — the Sunshine State — is one of America’s best destinations for tourists. Florida’s Twelfth Congressional District — which I have the distinct pleasure of representing — is no different.
The Food and Drug Administration admits it has been slow to issue guidance on biosimilar drugs that are expected to hit the U.S. market next year.
But Sally Howard, the agency’s deputy commissioner for policy planning and legislation, said the FDA is incredibly supportive of the new market, which experts say could lower prices of prescription drugs by 30 to 50 percent.